Status:
RECRUITING
Assessing Bone Fracture Healing Effect of Almonds
Lead Sponsor:
Aga Khan University Hospital, Pakistan
Collaborating Sponsors:
University of Karachi
PharmEvo Pvt Ltd
Conditions:
Femur Shaft Fracture
Tibia Fractures
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Femur and tibia shaft fractures are common after trauma with a burden of 5% and 20% respectively. Clinicians recommend costly bone strengthening drugs/supplements while treating bone fractures. These ...
Detailed Description
Trauma is a leading cause of morbidity and mortality in low middle income countries with road traffic accident as a common mechanism of trauma. Femur and tibia shaft fractures are common with a burden...
Eligibility Criteria
Inclusion
- Patients of 18 to 55 years of age of any gender.
- Agree and able to voluntary participate.
- Patients with trauma associated femur fracture and tibia shaft fracture arriving at hospital for treatment.
Exclusion
- Mentally retarded or patients with severe psychiatric illness.
- Patients are already on bone-strengthening drugs (bisphosphonates, vitamin D, strontium ranelate, teriparatide, etc.).
- Patients who require bone-strengthening drugs for osteoporosis or for any urgent need.
- Severe cardiovascular, hepatic, or renal disease.
- Known allergy or toxicity to Prunus dulcis (almonds) and/or vitamin D supplements.
Key Trial Info
Start Date :
August 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT07153302
Start Date
August 20 2024
End Date
July 1 2026
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Aga Khan University
Karachi, Pakistan, 74800